Cargando…
CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
Staphylococcus xylosus (S. xylosus)‐induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic tr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867972/ https://www.ncbi.nlm.nih.gov/pubmed/34180582 http://dx.doi.org/10.1111/1751-7915.13870 |
_version_ | 1784656154036535296 |
---|---|
author | Zheng, Si‐Di Zhang, Zhi‐Yun Ma, Jin‐Xin Qu, Qian‐Wei God'spowe, Bello‐Onaghise Qin, Yue Chen, Xue‐Ying Li, LU Zhou, Dong‐Fang Ding, Wen‐Ya Li, Yan‐Hua |
author_facet | Zheng, Si‐Di Zhang, Zhi‐Yun Ma, Jin‐Xin Qu, Qian‐Wei God'spowe, Bello‐Onaghise Qin, Yue Chen, Xue‐Ying Li, LU Zhou, Dong‐Fang Ding, Wen‐Ya Li, Yan‐Hua |
author_sort | Zheng, Si‐Di |
collection | PubMed |
description | Staphylococcus xylosus (S. xylosus)‐induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur‐loaded chitosan grafted with β‐cyclodextrins (CD‐g‐CS) nanoparticles (CT‐NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic S. xylosus. Moreover, CT‐NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of S. xylosus‐induced mastitis, CT‐NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for S. xylosus infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of S. xylosus infections. |
format | Online Article Text |
id | pubmed-8867972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88679722022-02-28 CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection Zheng, Si‐Di Zhang, Zhi‐Yun Ma, Jin‐Xin Qu, Qian‐Wei God'spowe, Bello‐Onaghise Qin, Yue Chen, Xue‐Ying Li, LU Zhou, Dong‐Fang Ding, Wen‐Ya Li, Yan‐Hua Microb Biotechnol Research Articles Staphylococcus xylosus (S. xylosus)‐induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur‐loaded chitosan grafted with β‐cyclodextrins (CD‐g‐CS) nanoparticles (CT‐NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic S. xylosus. Moreover, CT‐NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of S. xylosus‐induced mastitis, CT‐NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for S. xylosus infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of S. xylosus infections. John Wiley and Sons Inc. 2021-06-28 /pmc/articles/PMC8867972/ /pubmed/34180582 http://dx.doi.org/10.1111/1751-7915.13870 Text en © 2021 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Zheng, Si‐Di Zhang, Zhi‐Yun Ma, Jin‐Xin Qu, Qian‐Wei God'spowe, Bello‐Onaghise Qin, Yue Chen, Xue‐Ying Li, LU Zhou, Dong‐Fang Ding, Wen‐Ya Li, Yan‐Hua CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection |
title | CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection |
title_full | CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection |
title_fullStr | CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection |
title_full_unstemmed | CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection |
title_short | CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection |
title_sort | cd‐g‐cs nanoparticles for enhanced antibiotic treatment of staphylococcus xylosus infection |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867972/ https://www.ncbi.nlm.nih.gov/pubmed/34180582 http://dx.doi.org/10.1111/1751-7915.13870 |
work_keys_str_mv | AT zhengsidi cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT zhangzhiyun cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT majinxin cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT quqianwei cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT godspowebelloonaghise cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT qinyue cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT chenxueying cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT lilu cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT zhoudongfang cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT dingwenya cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection AT liyanhua cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection |